Build an AI swarm drone with Python, Crazyflie 2.1, Whisper voice control, and object detection for manual, autonomous flight ...
COLUMBIA — It took years for South Carolina legislators to broker a compromise to reform how the General Assembly picks state judges. Now, many of the same lawmakers who helped strike the deal last ...
Hyderabad: Undeterred by the controversy stirred by his threat to stop welfare schemes if the people of Jubilee Hills voted for the BRS, Chief Minister A Revanth Reddy on Saturday said that if the ...
Shares of Navin Fluorine International, one of the largest Indian manufacturers of speciality fluorochemicals, surged 17.3% in Friday’s intraday trade, October 31, to hit a fresh record high of ₹5,839 ...
Navin Fluorine’s shares surged up to 15% to a record Rs 5,729 after the company reported strong Q2FY26 results. Net profit jumped 152% to Rs 148 crore, while revenue rose 46% to Rs 758 crore. Robust ...
Navin Fluorine International Ltd witnessed a sharp rally of over 11% in early trade on Friday after the company reported stellar performance in its September quarter (Q2 FY26) results, driven by ...
Navin Fluorine International Ltd shares surged to a record high buoyed by strong quarterly earnings and fresh capital expenditure announcements. Investor sentiment turned positive after the company ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from Dr Reddy’s Laboratories ( ...
Dr Reddy’s Laboratories’ stock fell as much as 1 percent on Monday, October 27, after the drugmaker reported July-September quarter earnings that came in below expectations due to weak performance in ...
Hosted on MSN
Dr. Reddy’s Q2 Profit Up 14%
Dr. Reddy's Laboratories reported consolidated revenues of ₹8,805 crore in Q2FY26, up 9.8% year-on-year and 3% sequentially. Profit after tax rose 14% to ₹1,437 crore, while EBITDA stood at ₹2,351 ...
Dr Reddy’s Laboratories beat street estimates in the September quarter, with a revenue of ₹8,805 crore and profit after tax of ₹1,437 crore, buoyed by growth in branded markets and its nicotine ...
Hyderabad-based pharma major Dr Reddy Laboratories on Friday reported a consolidated net profit of ₹1,437.2 crore in the second quarter of the financial year 2025-26 (Q2FY26), marking a 14 per cent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results